Transoral robotic surgery (TORS) for laryngo-pharyngeal cancer - Experience of attending TORS advanced course

Ichiro Tateya, Seiji Ishikawa, Shigeru Hirano, Morimasa Kitamura, Tatsunori Sakamoto, Juichi Ito

Research output: Contribution to journalArticlepeer-review

Abstract

Transoral robotic surgery (TORS) was developed by Weinstein as a minimally invasive surgery mainly for laryngo-pharyngeal cancer. Da Vinci surgical system is a robot which enables to perform surgery safely and precisely under 3D vision. Since TORS had been cleared by FDA in 2009, it has been spreading explosively all over the world. However, it has not been approved by Pharmaceutical and Medical Devices Agency (PMDA) in Japan. We have attended the advanced course of TORS training held in Yonsei University prior to start the clinical trial of TORS and have performed radical tonsillectomy, tongue base resection, supraglottic laryngectomy, and piriform sinus resection for a cadaver. It was easy to adapt the movement of Da Vinci and transoral anatomy was a key to perform TORS safely. PMDA approval is desired in the otolaryngological field.

Original languageEnglish
Pages (from-to)319-323
Number of pages5
JournalOto-Rhino-Laryngology Tokyo
Volume56
Issue number5
Publication statusPublished - 01-10-2014
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Transoral robotic surgery (TORS) for laryngo-pharyngeal cancer - Experience of attending TORS advanced course'. Together they form a unique fingerprint.

Cite this